In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. David Kindness is a Certified Public Accountant (CPA) and an expert ...

Russian troops liberate Bondarnoye community in Donetsk region over past day — top brass The Ukrainian army lost roughly 1,300 troops in battles with Russian forces in all the frontline areas over the ...

The Olivier Award-winning Best Musical crosses the pond!